Biora Therapeutics, Inc. (BIORQ)

Biora Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	3.2	15.21	30.49	88.4	92.08	33.04
Cash & Short-Term Investments	3.2	15.21	30.49	88.4	92.08	33.04
Cash Growth	-74.57%	-50.10%	-65.51%	-4.00%	178.66%	-52.25%
Accounts Receivable	-	-	-	0.65	6.63	22.19
Other Receivables	0.87	0.83	0.83	-	-	0.63
Receivables	0.87	0.83	0.83	0.65	6.63	22.82
Inventory	-	-	-	-	-	10.94
Prepaid Expenses	1.95	2.44	3.63	6.12	8.52	6.48
Other Current Assets	0.05	0.59	3.17	3.6	19.11	1.37
Total Current Assets	6.05	19.07	38.12	98.78	126.34	74.65
Property, Plant & Equipment	2.19	2.77	3.14	3.67	8.11	15.89
Long-Term Investments	-	3	6	-	-	-
Goodwill	6.07	6.07	6.07	6.07	6.07	6.22
Other Intangible Assets	-	-	-	-	-	4.77
Other Long-Term Assets	0.19	0.3	0.2	0.33	13.92	0.2
Total Assets	14.51	31.22	53.53	108.84	154.44	101.73

Liabilities

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Accounts Payable	6.92	2.84	3.61	8.71	17.38	15.75
Accrued Expenses	16.27	6.92	4.35	12.23	17.76	17.19
Short-Term Debt	0.75	0.4	0.45	0.49	2.07	-
Current Portion of Long-Term Debt	38.59	1.98	-	-	0.07	0.24
Current Portion of Leases	0.72	0.9	0.89	0.01	0.27	0.73
Current Unearned Revenue	-	0.54	0.05	0.3	0.38	-
Other Current Liabilities	57.37	49.39	13.96	39.87	34.75	66.43
Total Current Liabilities	120.62	62.97	23.31	61.61	72.67	100.34
Long-Term Debt	-	43.74	127.81	126.39	160.16	72.05
Long-Term Leases	0.34	0.82	0.6	-	0.04	0.36
Other Long-Term Liabilities	0.18	25.11	4.09	5.81	28.56	12.86
Total Liabilities	121.13	132.64	155.81	193.82	261.43	185.6

Shareholders' Equity

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Common Stock	0	0.03	0.01	0.01	0.06	0.01
Additional Paid-In Capital	879.53	868.59	743.63	722.78	452.99	283.26
Retained Earnings	-967.08	-950.96	-826.84	-788.69	-541.27	-348.48
Treasury Stock	-19.08	-19.08	-19.08	-19.08	-18.77	-18.77
Total Common Equity	-106.63	-101.42	-102.29	-84.98	-106.99	-83.98
Shareholders' Equity	-106.63	-101.42	-102.29	-84.98	-106.99	-83.87
Total Liabilities & Equity	14.51	31.22	53.53	108.84	154.44	101.73

Additional Metrics

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Total Debt	40.4	47.83	129.75	126.89	162.61	73.37
Net Cash (Debt)	-37.2	-32.62	-99.26	-38.5	-70.54	-40.33
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-12.34	-20.68	-130.01	-100.09	-640.92	-2064.97
Filing Date Shares Outstanding	4.52	3.03	1.18	0.74	0.24	0.02
Total Common Shares Outstanding	3.68	2.78	0.89	0.73	0.22	0.02
Working Capital	-114.56	-43.9	14.81	37.17	53.67	-25.69
Book Value Per Share	-28.99	-36.43	-114.56	-116.81	-479.60	-4218.62
Tangible Book Value	-112.7	-107.49	-108.36	-91.05	-113.07	-94.97
Tangible Book Value Per Share	-30.64	-38.61	-121.36	-125.15	-506.82	-4770.68
Land	-	-	-	-	0.35	1.09
Buildings	0.85	0.8	0.75	0.44	0.44	9.49
Machinery	2.72	2.42	4.81	8.83	10.34	21.13
Construction In Progress	0.01	0.05	0.09	0.02	2.77	1.49

Data Source: S&P Global Market Intelligence Last updated: Sep 30, 2024

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 26, 2026

Data Sources Report a data error